You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Collecting duct Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Collecting Ducts Carcinoma: in Depth Exploration and

Recruiting
  • Collecting Duct Carcinoma
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale Tumori
    May 9, 2022

    Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma

    Recruiting
    • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    Feb 2, 2022

    Collecting Duct Carcinoma (Kidney) Trial in Milan (cabozantinib)

    Completed
    • Collecting Duct Carcinoma (Kidney)
    • Milan, Italy
      Giuseppe Procopio
    May 7, 2021

    Clear Cell Papillary Renal Tumor, Collecting Duct Carcinoma, Hereditary Leiomyomatosis and Renal Cell Carcinoma Trial in Los

    Recruiting
    • Clear Cell Papillary Renal Neoplasm
    • +10 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Oct 25, 2021

    Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

    Recruiting
    • Advanced Renal Cell Carcinoma
    • +8 more
    • Cabozantinib S-malate
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Jan 24, 2023

    Collecting Duct Carcinoma (Kidney) Trial in France (Bevacizumab)

    Completed
    • Collecting Duct Carcinoma (Kidney)
    • Angers, France
    • +18 more
    Mar 4, 2021

    Delving Into Participation Trends in Renal Cell Carcinoma

    Not yet recruiting
    • Renal Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Oct 16, 2023

      Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Recruiting
      • Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 5, 2023

      Moesin Expression in Clear Cell Renal Cell Carcinoma

      Completed
      • Renal Cell Carcinoma
      • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
      • (no location specified)
      Sep 20, 2023

      Renal Cell Carcinoma Trial (Sunitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 11, 2023

      ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

      Not yet recruiting
      • ccRCC
      • +20 more
      • (no location specified)
      Jul 6, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

      Available
      • Clear Cell Renal Cell Carcinoma
      • 89Zr-DFO-girentuximab
      • Los Angeles, California
        UCLA
      Oct 12, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 28, 2023

      Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

      Recruiting
      • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
      • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
      • Shanghai, Shanghai, China
        Shanghai Renji Hospital
      Sep 12, 2023

      Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • +2 more
      • (no location specified)
      May 14, 2023

      Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

      Recruiting
      • Advanced Renal Cell Carcinoma
      • ST-1898 tablets
      • Beijing, Beijing, China
        Peking University Cancer Hospital & Institute
      Nov 6, 2023

      Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic

      Recruiting
      • Renal Tumor Histology
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 28, 2022

        Renal Cell Carcinoma Trial (HS-10516)

        Not yet recruiting
        • Renal Cell Carcinoma
        • (no location specified)
        Sep 24, 2023

        Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

        Not yet recruiting
        • Renal Cell Carcinoma
        • +2 more
        • Implantable Microdevice (IMD)
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Jan 17, 2023

        Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Pembrolizumab injection
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Aug 20, 2023

        Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Sodium Pentaborate
        • Tabriz, East Azarbayejan, Iran, Islamic Republic of
          Imam Reza hospital and Clinic of Salamat
        Mar 23, 2023

        Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

        Not yet recruiting
        • Papillary Renal Cell Carcinoma
        • (no location specified)
        Nov 24, 2023

        Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

        Not yet recruiting
        • Renal Cell Carcinoma
        • Pucotenlimab Combined With Lenvatinib
        • Guangzhou, Other (Non U.s.), China
          Sun Yat-sen University Cancer Center
        Nov 10, 2023